We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · December 08, 2020

Metformin Use Is Associated With Increased eGFR in Youth With T1D

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Results From the Effects of MEtformin on CardiovasculaR Function in AdoLescents With Type 1 Diabetes (EMERALD) Study: A Brief Report of Kidney and Inflammatory Outcomes
Diabetes Obes Metab 2020 Nov 25;[EPub Ahead of Print], KL Tommerdahl, P Bjornstad, J Kendrick, M Cree-Green, AD Baumgartner, L Pyle, JEB Reusch, KJ Nadeau

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading